Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reporting drug defects.

H Hopkins

    FDA Consumer
    |August 10, 1978
    PubMed
    Summary
    This summary is machine-generated.

    A 7-year program involving pharmacists aids the Food and Drug Administration (FDA) in identifying and resolving drug safety issues. Consumers are now encouraged to report drug problems directly or through their pharmacists to enhance drug supply monitoring.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Can an interprofessional education tool improve healthcare professional confidence, knowledge and quality of inpatient diabetes care: a pilot study?

    Diabetic medicine : a journal of the British Diabetic Association·2013
    Same author

    Management of raised glucose, a clinical decision tool to reduce length of stay of patients with hyperglycaemia.

    Diabetic medicine : a journal of the British Diabetic Association·2012
    Same author

    210Pb and 137Cs as chronometers for salt marsh accretion in the Venice Lagoon - links to flooding frequency and climate change.

    Journal of environmental radioactivity·2007
    Same author

    Outpatient total body irradiation as a component of a comprehensive outpatient transplant program.

    Bone marrow transplantation·2002
    Same author

    Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes.

    Diabetes care·1999
    Same author

    A randomized trial of granulocyte colony-stimulating factor (Neupogen) starting day 1 vs day 7 post-autologous stem cell transplantation.

    Bone marrow transplantation·1998

    Area of Science:

    • Pharmacovigilance
    • Drug Safety Monitoring
    • Public Health Surveillance

    Background:

    • A long-standing program has utilized pharmacists to report adverse drug events.
    • This initiative aims to improve the detection and resolution of potential drug-related issues.
    • The program contributes to the Food and Drug Administration's (FDA) oversight of the national drug supply.

    Purpose of the Study:

    • To highlight the success of a pharmacist-led drug problem reporting system.
    • To encourage broader public participation in drug safety surveillance.
    • To strengthen the FDA's ability to monitor and ensure drug safety.

    Main Methods:

    • Leveraging a 7-year established program involving pharmacist cooperation.
    • Expanding the reporting channels to include direct consumer input.

    Related Experiment Videos

  • Utilizing reported data for FDA's regulatory and monitoring functions.

    • Main Results:

    • The program has successfully identified and rectified drug-related problems.
    • It has enhanced the FDA's surveillance of the overall drug supply.
    • Increased reporting is anticipated with consumer involvement.

    Conclusions:

    • Pharmacist-driven reporting is effective for drug safety.
    • Consumer participation can further bolster drug surveillance efforts.
    • Collaborative reporting enhances the FDA's regulatory oversight and public health protection.